{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:14:57Z","timestamp":1776914097620,"version":"3.51.2"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Urothelial carcinoma is the fourth most common genitourinary tumor with the majority of the tumor involving the urinary bladder. Only 5% involves the renal pelvis and ureter. Metastatic urothelial carcinoma of the renal pelvis frequently involves the lymph nodes, lung, liver, bone, and peritoneum. We share rare interesting <jats:sup>18<\/jats:sup>F-FDG PET\/CT images of a 60-year-old man with metastatic urothelial carcinoma of the renal pelvis to the bowel.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002797","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T19:20:08Z","timestamp":1572895208000},"page":"983-984","source":"Crossref","is-referenced-by-count":2,"title":["Renal Pelvis Urothelial Carcinoma With Bowel Metastases"],"prefix":"10.1097","volume":"44","author":[{"given":"Alex Cheen Hoe","family":"Khoo","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weng Heng","family":"Tang","sequence":"additional","affiliation":[{"name":"Oncology, Penang Adventist Hospital, George Town, Penang, Malaysia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005","volume":"107","year":"2011","journal-title":"BJU Int"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/RCT.0b013e31820d7a37","article-title":"Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location","volume":"35","year":"2011","journal-title":"J Comput Assist Tomogr"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ajur.2016.09.005","article-title":"Understanding the biology of urothelial cancer metastasis","volume":"3","year":"2016","journal-title":"Asian J Urol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"W497","DOI":"10.2214\/AJR.08.1945","article-title":"18 F-FDG PET\/CT of transitional cell carcinoma","volume":"193","year":"2009","journal-title":"Am J Roentgenol"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejrad.2015.12.017","article-title":"FDG-PET\/CT as a post-treatment restaging tool in urothelial carcinoma: comparison with contrast-enhanced CT","volume":"85","year":"2016","journal-title":"Eur J Radiol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clgc.2014.03.007","article-title":"Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma","volume":"12","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients","volume":"52","year":"1998","journal-title":"Urology"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2967\/jnumed.106.036350","article-title":"18F-FDG PET\/CT delayed images after diuretic for restaging invasive bladder cancer","volume":"48","year":"2007","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:00:41Z","timestamp":1695618041000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002797","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,31]]}}}